Back
FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Worldwide99%
PURITY
PURITY
Retatrutide 10MG (Box)
4.8(421)
A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic pathway regulation and receptor binding kinetics in preclinical research models. Premium Research Peptide.
Free shippingover $800
Damageprotection
Secure256-bit SSL
Certificate of Analysis
Third Party TestedJanoshik
Frequently Researched Together
Popular for your research
